FIELD: pharmaceuticals.
SUBSTANCE: invention relates to compounds of general formula (I), U is phenyl; each of R1 and R2 independently represents H, D, OH or C1-6-halogenalkyl; T is NO2, CN or CF3; X is CR4 or N; R4 is H; each of Y and Z independently represents C, CH or N; 
is a single or double bond; Q is phenyl, C4-7 carbocycle, 5-member heterocycle containing 1–2 heteroatoms, which are independently selected from O, S or N, or 5–6-member heteroaromatic ring containing 1–2 heteroatoms independently selected from O, S or N; each R3 independently represents H, D, halogen, C1-6-alkyl, C1-6-haloalkyl or 3–8-member cycloalkyl; m is 0 or 1; and n equals 0, 1, 2 or 3; as well as to their esters and pharmaceutically acceptable salts.
EFFECT: technical result is compounds of formula (I) as inhibitors of xanthine oxidase (XO) and carriers of 1 urate (URAT1).
11 cl, 3 tbl, 43 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PROCESS FOR PREPARING BIS(HYDROXYMETHYL)CYCLOBUTYL PURINES OR PYRIMIDINES | 1989 |
|
RU2041213C1 |
| TRICYCLIC COMPOUNDS AND THEIR USE | 2016 |
|
RU2724100C2 |
| ENANTIOMERICALLY PURE FLAVONE DERIVATIVES FOR TREATMENT OF PROLIFERATIVE DISORDERS AND METHODS OF THEIR OBTAINING | 2006 |
|
RU2418786C2 |
| SPIRO AMINO COMPOUNDS APPLICABLE FOR TREATING SLEEP DISORDERS AND DRUG ADDICTION | 2010 |
|
RU2562609C2 |
| DIHYDROPYRIMIDIN COMPOUNDS AND THEIR APPLICATION IN PHARMACEUTICALS | 2015 |
|
RU2682672C2 |
| SULPHONYLUREAS AND RELATED COMPOUNDS AND THEIR USE | 2016 |
|
RU2795512C2 |
| SULFONYL UREA AND RELATED COMPOUNDS AND USE THEREOF | 2016 |
|
RU2739356C2 |
| COMPOUND BASED ON DIHYDRONAPTHYRIDINONE, METHOD OF ITS OBTAINING, AND ITS USE IN MEDICINE | 2021 |
|
RU2809869C1 |
| SUBSTITUTED 2H-PYRAZOLE DERIVATIVE | 2016 |
|
RU2722363C2 |
| IMIDAZOPYRIDAZINES | 2012 |
|
RU2662443C2 |
